T1	intervention 0 15	Zoledronic acid
T2	condition 50 59	bone loss
T3	eligibility 63 156	premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer
T4	location 176 184	Austrian
T8	total-participants 969 985	Four hundred one
T9	outcome 1107 1124	overall bone loss
T6	outcome 1213 1230	Overall bone loss
T5	outcome 1460 1463	BMD
T7	intervention 571 580	tamoxifen
T10	intervention 602 611	goserelin
T11	intervention 713 724	anastrozole
